Overview
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 22, 2023 | FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with Clinical Decision-making in IVF | SANTA ANA, California - FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announces the addition of the Life Whisperer Genetics module to ... |
| Apr 11, 2023 | FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing | Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses Manufactured to cGMP-compliant standards to support production of recombinant proteins, monoclonal antibodies, and... |
| Jan 10, 2023 | FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production | Chemically defined, BalanCD HEK293 Viral Feed enhances viral vector production for gene therapy applications and viral vector-based vaccines FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free a... |
| Dec 6, 2022 | Shenandoah Biotechnology introduces expanded range of CTGrade recombinant proteins manufactured following cGMP practices | Shenandoah Biotechnology Inc., a FUJIFILM Irvine Scientific company and leading manufacturer of recombinant proteins, today announced it has expanded its CTGrade portfolio of cytokines and growth factors for cell and gene therapies manufact... |
| Mar 22, 2022 | Covid vaccines and drugs are free. But for many immunocompromised patients, protection comes at a cost | Less than a week after AnaptysBio dropped another indication for its lead drug, the biotech’s longtime CEO has decided to tap out. Hamza Suria tendered his resignation on Sunday, AnaptysBio revealed in an SEC filing, giving up the role he’d... |
| Mar 22, 2022 | Covid vaccines and drugs are free. But for many immunocompromised patients, protection comes at a cost | Sanofi is dipping its toes into a wide range of new technologies as CEO Paul Hudson looks to find its next big breakthrough. His latest pick comes from an emerging field that’s had plenty of buzz but few tangible results in drug development... |
| Mar 22, 2022 | Fujifilm to acquire Shenandoah Biotechnology, leading manufacturer of recombinant proteins | Fujifilm to acquire Shenandoah Biotechnology, leading manufacturer of recombinant proteins 22-03-2022 The acquisition offers customers worldwide a single point of access for cGMP cell culture solutions for biopharmaceuticals, and cell and g... |
| Mar 22, 2022 | Covid vaccines and drugs are free. But for many immunocompromised patients, protection comes at a cost | Among the tussle in the biotech space to finally “solve” solid tumors, a quiet biotech is now taking its shot — and has some VCs and some big-name scientific prowess from Fred Hutch to back up its efforts. Affini-T Therapeutics, aptly named... |
| Mar 22, 2022 | Covid vaccines and drugs are free. But for many immunocompromised patients, protection comes at a cost | Drugmakers spent close to $7 billion on consumer advertising in 2021. The exact final US media tally – $6.88 billion – is up just slightly from the $6.86 billion spent in 2020, according to Kantar’s media tracking data. Topping the list of ... |
Reviews 0
FAQ about FUJIFILM Irvine Scientific
When was FUJIFILM Irvine Scientific founded?
FUJIFILM Irvine Scientific was founded in 1970.
What has the press written about FUJIFILM Irvine Scientific?
Parsers VC has collected 17 articles mentioning FUJIFILM Irvine Scientific, among them “FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with Clinical Decision-making in IVF” (Jun 22, 2023) and “FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing” (Apr 11, 2023).
Is FUJIFILM Irvine Scientific still active?
Yes, FUJIFILM Irvine Scientific is active; its latest activity on Parsers VC dates from Jul 24, 2025.